A local retinal surgeon and ophthalmology professor will speak about age-related macular degeneration during a free webinar ...

Currently, there are no FDA-approved pharmacologic treatments for early AMD; for intermediate AMD, AREDS2 supplementation remains recommended to reduce progression risk. There are several unanswered ...

Patients with a confirmed diagnosis of OSA were compared to a control group without OSA to assess nonadvanced AMD progression. At 5 years, participants with OSA had a significantly higher risk of both ...

Significantly lower AMD risk compared with other agents in cohort study ...

Weaker handgrip strength is linked to higher AMD incidence, with a stronger association observed in women compared to men. The study used UK Biobank data, excluding participants under 50 or with ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU Medicine study in mice has shown. Pictured are color-stained retinal ...

CLEVELAND, Ohio — People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ancestry, suggests a new study from Case Western Reserve ...

It's an unfortunate fact of aging: Live long enough and, eventually, reading this sentence will get difficult, even impossible. Three in 10 Americans older than 80 have some form of age-related ...

EyePoint said on Thursday an independent safety committee found no new concerns in ​two late-stage trials of its experimental eye disease drug ‌Duravyu and recommended the studies continue unchanged.

Dear Savvy Senior: Is macular degeneration hereditary? My mother lost much of her vision from it before she died, and now at age 65, I’m concerned I may get it. What can you tell me? — Brown Eyed ...

A typical early symptom of age-related macular degeneration (AMD) is difficulty performing tasks under low-light conditions and in low-contrast surroundings. Patients may experience gradually ...